Table 3.
All patients | Without levothyroxine therapy | With levothyroxine therapy | ||||
---|---|---|---|---|---|---|
OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | |
Positive anti-TPO | 2.21 (1.14–4.28) | 0.018 | 2.28 (1.01–5.12) | 0.047 | 1.91 (0.59–6.21) | 0.281 |
Ultrasound signs of Hashimoto's thyroiditis | 1.13 (0.57–2.24) | 0.74 | 1.30 (0.55–3.06) | 0.552 | 0.86 (0.25–2.91) | 0.810 |
Levothyroxine therapy | 0.69 (0.36–1.33) | 0.27 | — | — | — | — |
TSH <0.5 mIU/l | 0.41 (0.19–0.88) | 0.02 | 0.30 (0.12–0.75) | 0.010 | 1.09 (0.23–5.16) | 0.914 |
Thyroid volume > 75th percentile (18 ml) | 1.21 (0.65–2.24) | 0.56 | 1.51 (0.77–2.96) | 0.234 | 0.30 (0.03–2.72) | 0.282 |
TSH: thyroid-stimulating hormone; anti-TPO: antibodies against thyroid peroxidase; anti-Tg: antithyroglobulin antibody. Antibodies against thyroglobulin were excluded from the multivariate regression analysis due to missing data.